Roche Launches $5.7 Billion Hostile Bid for Illumina (ILMN)

January 24, 2012 10:52 PM EST
Late Tuesday, Roche announced a proposal to acquire all outstanding shares of Illumina, Inc. (NASDAQ: ILMN) for $44.50 per share in cash, or an aggregate of approximately $5.7 billion on a fully diluted basis.

This offer represents a approx. 18% premium to Tuesday's NASDAQ close and a 64% premium over Illumina’s stock price on December 21, 2011 - the day before market rumors about a potential transaction between Roche and Illumina drove Illumina's stock price significantly higher.

Roche said has made multiple efforts to engage with Illumina in order to reach a negotiated transaction, but Illumina has been unwilling to participate in substantive discussions.

Severin Schwan, CEO of Roche Group, said, "Roche's all-cash offer of $44.50 per share represents full and fair value for Illumina and we expect that Illumina’s shareholders will welcome the opportunity to sell their shares at a significant premium to current market prices. It is our strong preference to enter into a negotiated transaction with Illumina, and we remain willing to engage in a constructive dialogue with Illumina to jointly develop an optimal strategy for maximizing the value of our combined business."


Serious News for Serious Traders! Try StreetInsider.com Premium Free!

You May Also Be Interested In





Related Categories

Hot List, Hot M&A, Mergers and Acquisitions, Rumors